Man Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Man Group’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-71,988	Closed	-$1.26M	–	2082
2020 Q4	$1.26M	Buy	71,988 +6,416	+10%	+$90K	0.01%	1346
2020 Q3	$767K	Buy	65,572 +19,564	+43%	+$260K	﹤0.01%	1436
2020 Q2	$598K	Buy	46,008 +23,667	+106%	+$284K	﹤0.01%	1417
2020 Q1	$207K	Sell	22,341 -338,872	-94%	-$4.74M	﹤0.01%	1464
2019 Q4	$6M	Sell	361,213 -373,504	-51%	-$6.06M	0.02%	923
2019 Q3	$12.2M	Buy	+734,717	New	+$10.2M	0.05%	486
2019 Q2	–	Sell	-356,624	Closed	-$6.14M	–	2072
2019 Q1	$6.14M	Buy	356,624 +183,181	+106%	+$2.9M	0.02%	804
2018 Q4	$2.22M	Buy	+173,443	New	+$2.63M	0.01%	1168

Man Group's OXFD Position: Q1 2021 in Review

Man Group sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 71,988 shares — an estimated $1.26M sold.

Man Group first reported a position in OXFD in Q4 2018 and held it in 8 quarters. The position peaked at $12.2M in Q3 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Man Group reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Man Group sold 71,988 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.26M.
Man Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2018 and held it in 8 quarters.
Man Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $12.2M in Q3 2019.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.